About: Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States. The company's lead product candidate is ISLA-101, a drug which is in second clinical-stage for the prevention and treatment of dengue fever and other mosquito vector borne diseases; and Galidesivir, a spectrum antiviral candidate with the potential to address multiple high-priority RNA virus threats. Island Pharmaceuticals Limited was founded in 2017 and is based in Hawthorn East, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.37 (-3.95%)
ILA ASX Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd share price
ILA price activity
Último preço
$ 0,370
Variação (24h)
-0,02 AUD (-3,95%)
Volume
79.95K
Volume (média 4 sem.)
-
Abertura
$ 0,39
Variação do dia
$ 0,37 - $ 0,39
Fechamento anterior
$ 0,38
Último negócio
06 Oct, 5:10 am GMT+0
Atrasado
06 Oct, 5:10 am GMT+0
ILA price performance
Atrasado
06 Oct, 5:10 am GMT+0
quote.marketSignals